- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00350935
Attention and Visual Perception in Schizophrenia: A Functional Magnetic Resonance Imaging (fMRI) Study
June 25, 2010 updated by: University Hospital, Strasbourg, France
Attention and Grouping of Visual Information: What is Disturbed in Patients With Schizophrenia?
The main objective of the study is to contribute to a better understanding of the physiopathology of schizophrenia, by studying causal relationships between cognitive deficits and the neurobiological basis for these deficits.
Processing visual information involves both automatic grouping processes and control processes.
Automatic grouping processes allow the building of a global configuration from local contour information.
It is necessary in order to recognize objects.
Control processes allow tending to and prioritizing information parts.
The paradigm the investigators use allows to dissociate these processes, and is used in order to characterize the impairments observed in patients with schizophrenia.
It is adapted to fMRI in order to explore the neurobiological basis of the deficits.
The investigators will examine whether functional disconnectivity between activated areas subtend the impairments observed in patients.
Study Overview
Study Type
Observational
Enrollment (Anticipated)
52
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Strasbourg, France, 67091
- Inserm U666 - Département de Psychiatrie, Hôpitaux Universitaires de Strasbourg
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 50 years (ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Primary care clinic, residents of Strasbourg
Description
Inclusion Criteria:
- Patients with schizophrenia (DSM-IV criteria)
- Healthy controls matched with patients on age, sex and education level
- Ages 18 to 50
- Signed informed consent
- Right-handed
Exclusion Criteria:
- No severe somatic illness
- No invalidating sensory disease
- No drug abuse, as defined by DSM-IV criteria
- No general anaesthesia in the past 3 months
- No intake of drugs affecting the CNS, except for patients
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Healthy volunteers
Healthy controls
|
One 30 minute session
|
|
Patients
Patients with schizophrenia
|
One 30 minute session
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2006
Study Completion (ACTUAL)
April 1, 2009
Study Registration Dates
First Submitted
July 10, 2006
First Submitted That Met QC Criteria
July 10, 2006
First Posted (ESTIMATE)
July 11, 2006
Study Record Updates
Last Update Posted (ESTIMATE)
June 28, 2010
Last Update Submitted That Met QC Criteria
June 25, 2010
Last Verified
June 1, 2010
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 3456
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Schizophrenia
-
First Affiliated Hospital of Fujian Medical UniversityNot yet recruiting
-
Fundació Institut de Recerca de l'Hospital de la...Recruiting
-
Organon and CoCompletedSchizophrenia, Paranoid | Schizophrenia, Disorganized | Schizophrenia, Undifferentiated
-
Organon and CoCompletedSchizophrenia, Paranoid | Schizophrenia, Disorganized | Schizophrenia, Undifferentiated
-
Newron Pharmaceuticals SPARecruitingTreatment-resistant SchizophreniaUnited States, India
-
All India Institute of Medical Sciences, BhubaneswarCompletedTreatment Resistant SchizophreniaIndia
-
Bradley LegaRecruiting
-
Central Institute of Mental Health, MannheimRecruitingSchizophrenia | Treatment Resistant SchizophreniaGermany
-
Shanghai Zhongze Therapeutics Co., Ltd.Yale UniversityNot yet recruiting
-
Ole Köhler-ForsbergAarhus University HospitalRecruiting
Clinical Trials on fMRI
-
Weill Medical College of Cornell UniversityMemorial Sloan Kettering Cancer CenterWithdrawnBrain TumorsUnited States
-
Brighton & Sussex Medical SchoolCompletedDepressionUnited Kingdom
-
Van Boven, Robert W., M.D.Massachusetts Institute of Technology; The Geneva FoundationUnknownTraumatic Brain Injury | Post Traumatic Stress DisorderUnited States
-
Centre Hospitalier Universitaire de Saint EtienneUniversity Hospital of Saint-EtienneCompleted
-
Centre Hospitalier Universitaire de Saint EtienneTerminatedMagnetic Resonance Imaging | Neuronal ActivityFrance
-
Centre Hospitalier Universitaire, AmiensCHRU LILLERecruitingStroke | EEG | fNIRS | Temporal Perturbation | Virtual Lesion | TMS | Stroke Lesions | Action SlowingFrance
-
Boston VA Research Institute, Inc.Mclean Hospital; Cambridge Health Alliance; Northeastern UniversityRecruitingSchizophrenia | Treatment-resistant Schizophrenia | Auditory HallucinationUnited States